Caisse DE Depot ET Placement DU Quebec Has $42.94 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Caisse DE Depot ET Placement DU Quebec decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 53.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 143,047 shares of the company’s stock after selling 161,772 shares during the quarter. Caisse DE Depot ET Placement DU Quebec’s holdings in HCA Healthcare were worth $42,936,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Congress Wealth Management LLC DE grew its position in shares of HCA Healthcare by 3.4% during the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock worth $312,000 after buying an additional 34 shares during the period. Evergreen Private Wealth LLC raised its holdings in HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock worth $3,838,000 after purchasing an additional 35 shares during the period. Mediolanum International Funds Ltd increased its position in shares of HCA Healthcare by 0.3% in the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock valued at $3,153,000 after buying an additional 36 shares in the last quarter. Prairie Wealth Advisors Inc. lifted its holdings in HCA Healthcare by 6.1% during the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock worth $210,000 after acquiring an additional 40 shares in the last quarter. Finally, Whittier Trust Co. raised its position in shares of HCA Healthcare by 3.6% during the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company’s stock worth $359,000 after purchasing an additional 41 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

NYSE:HCA opened at $348.11 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $85.71 billion, a price-to-earnings ratio of 15.84, a P/E/G ratio of 1.10 and a beta of 1.48. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The stock’s 50 day moving average price is $331.79 and its two-hundred day moving average price is $330.75.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The company had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. During the same period in the prior year, the firm earned $5.36 earnings per share. The company’s revenue was up 5.7% on a year-over-year basis. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a $0.72 dividend. The ex-dividend date is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.83%. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.81%.

Analyst Ratings Changes

HCA has been the subject of a number of research reports. Truist Financial lowered their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Baird R W cut HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Robert W. Baird reaffirmed a “neutral” rating and set a $336.00 price objective (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. KeyCorp cut their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Finally, Barclays cut their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $381.13.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.